|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2007-9-24
|
|
pubmed:abstractText |
Patients with chronic allograft nephropathy (CAN) very frequently suffer anemia. Correction of anemia by means of recombinant erythropoietin (rEpo) is possible and useful, but safety and efficacy must be assessed.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0041-1345
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
39
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2245-7
|
|
pubmed:meshHeading |
pubmed-meshheading:17889152-Adult,
pubmed-meshheading:17889152-Anemia,
pubmed-meshheading:17889152-Blood Pressure,
pubmed-meshheading:17889152-Cadaver,
pubmed-meshheading:17889152-Chronic Disease,
pubmed-meshheading:17889152-Creatinine,
pubmed-meshheading:17889152-Erythropoietin,
pubmed-meshheading:17889152-Female,
pubmed-meshheading:17889152-Glomerular Filtration Rate,
pubmed-meshheading:17889152-Humans,
pubmed-meshheading:17889152-Kidney Transplantation,
pubmed-meshheading:17889152-Male,
pubmed-meshheading:17889152-Middle Aged,
pubmed-meshheading:17889152-Safety,
pubmed-meshheading:17889152-Tissue Donors,
pubmed-meshheading:17889152-Transplantation, Homologous
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Erythropoietin safety and efficacy in chronic allograft nephropathy.
|
|
pubmed:affiliation |
Hospital Universitario Central de Asturias and Hospital Clinic i Provincial de Barcelona, Barcelona, Spain. jbaltar@hca.es
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study
|
